相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo
Solene Marie et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide
Geraldine Pottier et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes
Aniv Mann et al.
AAPS JOURNAL (2015)
Role of organic cation transporters in drug-drug interaction
Hermann Koepsell
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-Erlotinib
Alexander Traxl et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes
Marc Le Vee et al.
TOXICOLOGY IN VITRO (2015)
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
Mara R. Livezey et al.
XENOBIOTICA (2014)
Identification of Novel Substrates and Structure-Activity Relationship of Cellular Uptake Mediated by Human Organic Cation Transporters 1 and 2
Ramon Hendrickx et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement
Ken Grime et al.
DRUG METABOLISM AND DISPOSITION (2013)
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Joerg Koenig et al.
PHARMACOLOGICAL REVIEWS (2013)
Clinical Response and Side Effects of Metoclopramide Associations With Clinical, Demographic, and Pharmacogenetic Parameters
Henry P. Parkman et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite
H. X. Zheng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
The Drug Transporter-Metabolism Alliance: Uncovering and Defining the Interplay
Leslie Z. Benet
MOLECULAR PHARMACEUTICS (2009)
In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system
Bo Feng et al.
DRUG METABOLISM AND DISPOSITION (2008)
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model
A Doran et al.
DRUG METABOLISM AND DISPOSITION (2005)
The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6
Z Desta et al.
DRUG METABOLISM AND DISPOSITION (2002)
分享论文
